Featured Professionals: Nick Petrick, Stephan Doering

Getting vital medicines to the patients that need them requires more than timely delivery. As treatments become more complex and care moves beyond hospitals, pharma logistics providers must meet exacting specifications for temperature, handling, and tracking.

“For companies with the expertise to manage these demands, there’s a growing opportunity to become essential partners to healthcare customers,” says Nick Petrick, a director in our Transportation & Logistics Group. “That’s winning the attention of investors.”

Below, we explore this space, its key areas of growth potential, and what made our recent client Life Couriers such a compelling opportunity.

Meeting Evolving Healthcare Needs

An aging population and more prevalent chronic conditions are increasing pharmaceutical demand worldwide. At the same time, the growth of biologics and other advanced treatments is creating more shipments that require carefully controlled temperatures and specialized handling to preserve their effectiveness.

Today, these deliveries also must reach more locations. Treatment is shifting from hospitals to homes, outpatient centers, and other community settings, while online pharmacies and mail-delivery services are raising expectations for fast, reliable delivery directly to patients. Clinical trials are becoming more geographically dispersed as well, adding complexity to the movement of samples and supplies.

Managing these needs requires capabilities that many healthcare companies prefer to access through specialist partners. Outsourcing logistics can help them control costs, manage regulatory requirements, and adapt as shipment volumes and delivery needs change. In fact, the global pharma logistics sector is expected to grow from $94.7B to $139.1B by 2029 at an 8% CAGR, around 1.5 times faster than the overall logistics market.¹

Within this space, cold chain is one of the fastest growing segments with a 9% CAGR.² “Growth in biologics, cell and gene therapies, and specialty medicines is increasing the need for temperature control, cryogenic storage, and real time monitoring,” notes Petrick. “Across these areas, high regulatory requirements and therapeutic complexity make reliability, compliance, visibility, and specialized cold chain capabilities critical differentiators for logistics providers.”

Technology is quickly becoming an increasingly important factor. Automation and predictive logistics tools can improve efficiency, while shipment-level tracking helps providers monitor sensitive deliveries and meet quality requirements. “For customers, the value lies in combining those tools with people and processes that can consistently manage many distribution lanes, many temperature profiles, and many small drops,” says Stephan Doering, a managing director in our Healthcare & Life Sciences Group.

Select Growth Opportunities 

Throughout this expanding market, several areas offer particularly compelling opportunities for providers with dedicated expertise.

Direct-to-Patient Delivery: Home-based care and growing demand for home-care supplies are increasing the need for dependable delivery to individual patients. Providers that can manage these final steps help connect a more dispersed healthcare system.

Cold Chain Logistics: Biologics, vaccines, and advanced therapies like GLP-1s depend on temperature-controlled storage and transportation. Their growth is increasing demand for providers that can maintain the required conditions throughout a shipment’s journey.

Radiopharmaceuticals: Expanding diagnostic and therapeutic applications are creating highly time-sensitive logistics needs. These hazardous products require tightly coordinated manufacturing and delivery, with little room to hold inventory or absorb delays.

Cell and Gene Therapies: Complex handling and transportation requirements can make it difficult for patients to access these treatments. Logistics providers with targeted solutions have an opportunity to help overcome those obstacles.

Specialized Storage: Healthcare systems, biopharma companies, and contract manufacturers also need outside storage capacity. Providers offering warehousing and biostorage can help customers address space constraints and manage overflow in a compliant manner.

Building Broader Relationships via M&A

Across these areas of pharma logistics, growth can take several forms: deeper expertise in one sub-vertical, service, or region, new complementary capabilities, or international expansion to serve customers in more markets.

Pharma companies are often looking to consolidate their number of vendors, preferring to give more business to trusted providers with proven capabilities across sensitive shipments, complex logistics, and storage. Acquisitions can help providers meet those needs by adding local relationships, specialized knowledge, or new services.

The opportunity extends beyond building a larger network: “Combining data systems, coordinating customer relationships, and making complementary services available across the business can create a more useful and valuable logistics offering,” says Petrick.

And due to the sector's significant scale advantages, from network density to broader geographic coverage, strategics and private equity buyers are both drawn to the space. “There's a clear value creation strategy for private equity to consolidate, gain scale, and leverage their network to cross-sell, with the ultimate goal of selling to a strategic,” adds Doering.

Life Couriers: Specialized Expertise with Global Reach

Life Couriers illustrates how specialized capabilities and international reach can come together. Headquartered in Germany, the company is an integrated group of logistics operators focused on life science and healthcare. Harris Williams advised Life Couriers, a portfolio company of AUCTUS Capital Partners AG, on its sale to JLL Partners.

The company operates in six segments: radiopharmaceuticals, life science, stem cell onboard, direct-to-patient, pharma freight, and emergency logistics. Its locations across the U.S., Europe, Central America, and Asia enable it to address a broad range of sensitive, time-critical delivery needs.

Those capabilities also provide multiple paths for continued growth. Life Couriers’ specialty markets remain fragmented, creating opportunities to acquire niche providers, share proven operating practices, and offer customers a more coordinated service. Its partnership with JLL Partners brings additional industry relationships and support, particularly in radiopharmaceuticals and direct-to-patient delivery.

“Together, JLL Partners and Life Couriers will be well positioned to expand the company’s commercial strategy, scale its global operations, and support long-term growth,” says Petrick.

Vital to Next-Gen Care

The global healthcare industry is only getting more complex, with highly fragmented care delivery, greater prevalence of chronic disease, and the proliferation of temperature sensitive therapies. As a result, the pharma logistics sector is increasingly vital to modern healthcare delivery, providing operational precision and specialized handling expertise to keep medicines effective and prevent costly product losses.

Businesses that pair deep expertise with reliable service, effective technology, and thoughtful expansion are poised for long-term success. “The stakes are high in pharma logistics. Customers depend on specialized providers that can reliably meet strict regulatory and operational requirements across the healthcare ecosystem,” says Petrick. “Because of the scarcity value of companies that can do this well, interest from both strategic and financial investors is accelerating.”

To further discuss M&A opportunities within pharma logistics, please contact our senior professionals.

1. Global Pharmaceuticals Logistics Market 2025-2029; Kearney analysis

2. Global Pharmaceuticals Logistics Market 2025-2029; Kearney analysis